Search

everythinglearnresearchcommunity

for

Search:↓

Stem cells from elderly skin can become neurons, offering potential for brain therapy.

Special cells can help regrow hair in alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

A new type of nerve cell involved in itch perception was discovered.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

HPV8 E6 gene causes growth of certain skin stem cells.

A new mouse model effectively mimics vitiligo for research and drug testing.

The assay effectively identifies compounds that affect immune cell activation.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.